Aptevo Therapeutics

APVO

Börsenwert 2,91 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Dimensional Fund Advisors Austin, Texas	2,75 Mio. $	–	–	–
2	2 Perceptive Advisors New York	2,53 Mio. $	–	–	–
3	3 Sessa Capital New York	2,5 Mio. $	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	2,14 Mio. $	–	–	–
5	5 Acadian Asset Management Boston, Massachusetts	1,27 Mio. $	–	–	–
6	6 Emerald Acquisition Seattle, Washington	1,13 Mio. $	–	–	–
7	7 BlackRock Institutional Trust San Francisco, California	1,07 Mio. $	–	–	–
8	8 BlackRock Fund Advisors San Francisco, California	1,06 Mio. $	–	–	–
9	9 GLG Partners London, United Kingdom	1,02 Mio. $	–	–	–
10	10 D.E. Shaw & Co New York	962.000 $	–	–	–
11	CL 11 CSS LLC Chicago, Illinois	906.000 $	–	–	–
12	12 Goldman Sachs New York	881.000 $	–	–	–
13	13 Charles Schwab San Francisco, California	877.000 $	–	–	–
14	14 State Street Boston, Massachusetts	821.000 $	–	–	–
15	15 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	818.000 $	–	–	–
16	16 Morgan Stanley New York	665.000 $	–	–	–
17	17 Renaissance Technologies New York	663.000 $	–	–	–
18	18 Northern Trust Chicago, Illinois	593.000 $	–	–	–
19	19 AQR Arbitrage Greenwich, Connecticut	540.000 $	–	–	–
20	20 TIAA CREF Investment Management New York	501.000 $	–	–	–
21	21 Millennium Management New York	429.000 $	–	–	–
22	22 Bank of New York Mellon New York	400.000 $	–	–	–
23	23 Norges Bank Oslo, Norway	383.000 $	–	–	–
24	24 Fidelity Investments Boston, Massachusetts	360.000 $	–	–	–
25	25 BlackRock Group London, United Kingdom	355.000 $	–	–	–

Aptevo Therapeutics APVO Börsenwert 2,91 Mio. $

Aptevo Therapeutics

APVO

Börsenwert 2,91 Mio. $